In order to raise awareness of lung cancer and to provide information on patients with the disease, Carevive is pleased to provide some patient experience insights our Carevive SMART Dataset.
By collecting this information, Carevive is creating an awareness of the wide variety of concerns that patients with breast cancer have as they begin treatment. Providing these important data to clinicians helps to reinforce that each patient may have a set of data that makes their situation truly unique so that therapy can be provided accordingly. Breast cancer by numbers.…
Gynecologic Cancers by the numbers. In this infographic, we'd like to highlight some important facts and figures on gynecologic cancers as well as key learnings from Carevive SMART Data™.
Acute myeloid leukemia (AML) by numbers. In this infographic, we'd like to highlight some important facts and figures on AML as well as key learnings from Carevive SMART Data™.
At Carevive we are marking Multiple Myeloma Awareness Month with a renewed commitment to improving the care of patients with multiple myeloma and generating patient experience data that will help achieve this goal. In this infographic, we'd like to highlight some important facts and figures on mutiple myeloma as well as key learnings from Carevive SMART Data™.
Carevive's CEO, Bruno Lempernesse, is featured in this Healthcare Podcast episode hosted by James Kent from Market Scale. Bruno shares his thoughts on leadership, what brought him to Carevive, challenges in the health care industry, and his vision for Carevive.
Carevive OPT-IN® is a novel real-world Patient Experience database consisting of EHR-derived clinical data and longitudinal Patient-Reported Outcomes (PRO).
Carevive is aligned with and strongly supports CMS’ announcement of the OCF Model as this will benefit patients and improve care. We believe unequivocally this program provides an invaluable opportunity for U.S.-based cancer programs to transform their practice in delivering better quality, patient-centered, value-based care.
Carevive Systems, a leading oncology-focused health technology company, announced today that it has received Series C funding from new investors Philips Health Technology Ventures and Debiopharm Innovation Fund.